aTyr Pharma (LIFE) Tops Q4 EPS by 2c

Note: EPS may not be comparable

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.39), $0.02 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Sunbelt Rentals Holdings, Inc. (SUNB) Reports Q2 EPS of $1.18
• ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance